|
Status |
Public on Feb 23, 2016 |
Title |
Expression data from LNCaP cells |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Prostate Cancer Stem Cells (CSCs) are considered one of the main reasons the tumor recurrence after chemotherapy. Here we employed a chemoresistant xenograft prostate cancer model in NOD/SCID mice and found CD54 is a reliable new marker for prostate CSCs. Gene expression profile were utilized to analyze stemness-related genes in cancer stem cells.
|
|
|
Overall design |
12 Male NOD/SCID mice were obtained from the Animal Center of the Chinese Academy of Medical Science (Beijing, China). For xenograft generation, 1×106 LNCaP cells were subcutaneously injected into the backs of NOD/SCID mice (n=24). When tumors reached a diameter of 5 mm after 3 d, mice were randomly divided into two groups without castration (12 per group). Mice in the treatment group were administered with cisplatin at a dose of 5 mg/kg every 3 d for 30 d. Mice in the control group were treated with vehicle PBS. Tumors were taken out for microarray assay after 30 d.
|
|
|
Contributor(s) |
Li C |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
Submission date |
Feb 23, 2016 |
Last update date |
Mar 15, 2019 |
Contact name |
Chong Li |
E-mail(s) |
lichong87@126.com
|
Organization name |
Institute of Biophysics, Chinese Academy of Sciences
|
Street address |
15 Datun Road
|
City |
Beijing |
ZIP/Postal code |
100101 |
Country |
China |
|
|
Platforms (1) |
GPL16686 |
[HuGene-2_0-st] Affymetrix Human Gene 2.0 ST Array [transcript (gene) version] |
|
Samples (2) |
|
Relations |
BioProject |
PRJNA312902 |